JohnJEngemannMD

PubMed

• 56 citations
  Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
  Wang, J. P., Wolfe, C., Tomashek, K., Patterson, T., Gomez, C., Marconi, V., Jain, M., Yang, O., Paules, C., Palacios, G., Grossberg, R., Harkins, M., Mularski, R., Er...> ;The Lancet. Respiratory Medicine. 2022 Sep 1
• 6 citations
  In pursuit of the holy grail: Improving C. difficile testing appropriateness with iterative electronic health record clinical decision support and targeted test restri...
  Norah S. Karlovich, Suchita Shah Sata, Brian Griffith, Ashley Coop, Ibukunoluwa C. Kalu, John J. Engemann, Jessica Seidelman, Nicholas A Turner, Christopher R. Polage,...> ;Infection Control and Hospital Epidemiology. 2021 Jun 4
• 7 citations
  Social Disadvantage, Politics, and Severe Acute Respiratory Syndrome Coronavirus 2 Trends: A County-level Analysis of United States Data.
  Ahmad Mourad, Nicholas A Turner, Arthur W. Baker, Nwora Lance Okeke, Shanti Narayanasamy, Robert Rolfe, John J. Engemann, Gary M. Cox, Jason E. Stout> ;Clinical Infectious Diseases. 2021 May 18
• 40 citations
  Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection.
  David P. Holland, Carol Dukes Hamilton, Amy C. Weintrob, John J. Engemann, Ellen R. Fortenberry, Charles A. Peloquin, Jason E. Stout> ;Pharmacotherapy. 2009 May 1
• 6 citations
  Mortality and time to extubation in severe hospital-acquired pneumonia
  Sarah M. Connelly, Jane V. Trinh, Melissa D. Johnson, Elizabeth Dodds-Ashley, Jason E. Stout, John J. Engemann, N. Deborah Friedman, Donald Kaye, Keith S. Kaye> ;American Journal of Infection Control. 2009 Mar 1
• 40 citations
  Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.
  Preeta K. Kutty, Stephen R. Benoit, Christopher W. Woods, Arlene C. Sena, Susanna Naggie, Joyce Frederick, John J. Engemann, Sharon Evans, Brian C. Pien, Shailendra N....> ;Infection Control and Hospital Epidemiology. 2008 Mar 1
• 168 citations
  Non-HACEK gram-negative bacillus endocarditis.
  Susan C. Morpeth, David R. Murdoch, Christopher H. Cabell, Adolf W. Karchmer, Paul A. Pappas, Donald P. Levine, Francisco Nacinovich, Pierre Tattevin, Nuria Fernández-...> ;Annals of Internal Medicine. 2007 Dec 18
• 25 citations
  Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread.
  Jay R. McDonald, Charlene Carriker, Brian C. Pien, Jane V. Trinh, John J. Engemann, Lizzie J. Harrell, M. Oden, David T. Tanaka, Ronald N. Goldberg, Daniel J. Sexton, ...> ;The Pediatric Infectious Disease Journal. 2007 Aug 1
• 151 citations
  Early Surgery in Patients with Infective Endocarditis: A Propensity Score Analysis
  Olcay Aksoy, Daniel J. Sexton, Andrew Wang, Paul A. Pappas, Wissam M. Kourany, Vivian H. Chu, Vance G. Fowler, Christopher W. Woods, John J. Engemann, G. Ralph Corey, ...> ;Clinical Infectious Diseases. 2007 Feb 1
• 256 citations
  Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia
  Martin E. Stryjewski, Lynda A. Szczech, Daniel K. Benjamin, Jula K. Inrig, Zeina A. Kanafani, John J. Engemann, Vivian H. Chu, Maria Joyce, L. Barth Reller, G. Ralph C...> ;Clinical Infectious Diseases. 2007 Jan 15
• 42 citations
  Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa
  Keith S. Kaye, Zeina A. Kanafani, Ashley E. Dodds, John J. Engemann, Stephen G. Weber, Yehuda Carmeli> ;Antimicrobial Agents and Chemotherapy. 2006 Jun 1
• 44 citations
  Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia
  Jula K. Inrig, Shelby D. Reed, Lynda A. Szczech, John J. Engemann, Joëlle Y. Friedman, G. Ralph Corey, Kevin A. Schulman, L. Barth Reller, Vance G. Fowler> ;Clinical Journal of the American Society of Nephrology. 2006 May 1
• 60 citations
  Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae
  Deverick J. Anderson, John J. Engemann, Lizzie J. Harrell, Yehuda Carmeli, L. Barth Reller, Keith S. Kaye> ;Antimicrobial Agents and Chemotherapy. 2006 May 1
• 41 citations
  Favorable impact of an infection control network on nosocomial infection rates in community hospitals
  Keith S. Kaye, John J. Engemann, Evelyn M. Fulmer, Connie C. Clark, Edwin M. Noga, Daniel J. Sexton> ;Infection Control and Hospital Epidemiology. 2006 Feb 28
• 120 citations
  Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
  John J. Engemann, Joëlle Y. Friedman, Shelby D. Reed, Robert I. Griffiths, Lynda A. Szczech, Keith S. Kaye, Martin E. Stryjewski, L. Barth Reller, Kevin A. Schulman, G...> ;Infection Control and Hospital Epidemiology. 2005 Jun 1
• 160 citations
  Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia
  Shelby D. Reed, Joëlle Y. Friedman, John J. Engemann, Robert I. Griffiths, Kevin J. Anstrom, Keith S. Kaye, Martin E. Stryjewski, Lynda A. Szczech, L. Barth Reller, G....> ;Infection Control and Hospital Epidemiology. 2005 Feb 1
• 82 citations
  Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management.
  Keith S Kaye, John J Engemann, Henry S Fraimow, Elias Abrutyn> ;Infectious Disease Clinics of North America. 2004 Sep 1
• 8 citations
  Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals.
  Jay R. McDonald, John J. Engemann, Keith S. Kaye, Daniel J. Sexton> ;Infection Control and Hospital Epidemiology. 2004 Aug 1
• 125 citations
  Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost.
  Sarah A. McGarry, John J. Engemann, Kenneth E. Schmader, Daniel J. Sexton, Keith S. Kaye> ;Infection Control and Hospital Epidemiology. 2004 Jun 1
• 11 citations
  Control of Nosocomial Acquisition of Vancomycin-Resistant Enterococcus Through Active Surveillance of Hemodialysis Patients
  R. Neal Axon, John J. Engemann, James Butcher, Kathy Lockamy, Keith S. Kaye> ;Infection Control and Hospital Epidemiology. 2004 May 1
• 1 citations
  Tuberculosis Transmission from a Patient with Skin Lesions and a Negative Sputum Smear
  Jason E. Stout, John J. Engemann, Carol Dukes Hamilton> ;The New England Journal of Medicine. 2004 Jun 10
• 75 citations
  Reference Group Choice and Antibiotic Resistance Outcomes
  Keith S. Kaye, John J. Engemann, Essy Mozaffari, Yehuda Carmeli> ;Emerging Infectious Diseases. 2004 Jun 1
• 59 citations
  Risk Factors for Postoperative Mediastinitis Due to Methicillin-Resistant Staphylococcus aureus
  E. S. Dodds Ashley, D. N. Carroll, John J. Engemann, Anthony D. Harris, Vance G. Fowler, Daniel J. Sexton, Keith S. Kaye> ;Clinical Infectious Diseases. 2004 Jun 1
• 294 citations
  Early Predictors of In-Hospital Death in Infective Endocarditis
  Vivian H. Chu, Christopher H. Cabell, Daniel K. Benjamin, Erin F. Kuniholm, Vance G. Fowler, John J. Engemann, Daniel J. Sexton, G. Ralph Corey, Andrew Wang> ;Circulation. 2004 Apr 13
• 59 citations
  Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.
  Jason E. Stout, John J. Engemann, Allen C. Cheng, Ellen R. Fortenberry, Carol Dukes Hamilton> ;American Journal of Respiratory and Critical Care Medicine. 2003 Mar 15
• Join now to see all